...
首页> 外文期刊>Hormone and Metabolic Research >SDH Subunit Mutation Status in Saliva: Genetic Testing in Patients with Pheochromocytoma
【24h】

SDH Subunit Mutation Status in Saliva: Genetic Testing in Patients with Pheochromocytoma

机译:唾液中SDH亚基突变状态:嗜铬细胞瘤患者的基因检测

获取原文
获取原文并翻译 | 示例
           

摘要

Germline mutations occur in up to 30-40% of pheochromocytoma/paraganglioma, with mutations in the succinate dehydrogenase (SDH) subunits B (SDHB) and D (SDHD) being the most common. Blood samples are favored for obtaining high quality DNA, however, leukocytes can also be obtained by collecting saliva. The aim of this study was to determine whether SDHB and SDHD gene mutations in patients with pheochromocytoma/paraganglioma could be determined using a salivary sample. Paired blood and salivary samples were collected from 30 patients: 9 SDHB mutation positive, 13 with a SDHD mutation, and 8 without any SDHx mutations. The Oragene DISCOVER kit was used to collect and extract DNA from saliva. Blood DNA was extracted from EDTA blood samples. The DNA purification and concentration were measured by spectrophotometry. The 8 exons of SDHB and the 4 exons of SDHD were amplified and sequenced by PCR-based bidirectional Sanger sequencing. Total DNA yields from blood DNA were similar to those obtained from saliva DNA [mean (+/- SD) saliva vs. blood DNA concentration 514.6 (+/- 580.8)ng/mu l vs. 360.9 (+/- 262.7)ng/mu l; p=0.2)]. The purity of the saliva DNA samples was lower than that of blood [mean OD260/OD280 ratio 1.78 (+/- 0.13) vs. 1.87 (+/- 0.04); p=0.001, respectively], indicating more protein contamination in the saliva-extracted DNA. This study shows that salivary DNA collected from patients with pheochromocytoma/paraganglioma is a good alternative for extraction of genomic DNA for its high DNA concentration and acceptable purity and can be used as an alternative to blood derived DNA in screening for SDHB and SDHD mutations.
机译:胚系突变发生在多达30-40%的嗜铬细胞瘤/副神经节瘤中,其中最常见的是琥珀酸脱氢酶(SDH)亚基B(SDHB)和D(SDHD)突变。血液样品易于获得高质量的DNA,但是也可以通过收集唾液来获得白细胞。这项研究的目的是确定是否可以使用唾液样本确定嗜铬细胞瘤/副神经节瘤患者的SDHB和SDHD基因突变。从30例患者中采集配对的血液和唾液样本:9例SDHB突变阳性,13例有SDHD突变和8例无任何SDHx突变。 Oragene DISCOVER试剂盒用于从唾液中收集和提取DNA。从EDTA血液样本中提取血液DNA。通过分光光度法测量DNA的纯化和浓度。 SDHB的8个外显子和SDHD的4个外显子通过基于PCR的双向Sanger测序进行扩增和测序。血液DNA的总DNA产量与唾液DNA的产量相似[平均(+/- SD)唾液与血液DNA浓度514.6(+/- 580.8)ng /μl对360.9(+/- 262.7)ng /μl/ ml l p = 0.2)]。唾液DNA样品的纯度低于血液纯度[OD260 / OD280平均比1.78(+/- 0.13)对1.87(+/- 0.04); p分别为0.001],表明唾液提取的DNA中存在更多的蛋白质污染。这项研究表明,从嗜铬细胞瘤/副神经节瘤患者中收集的唾液DNA具有较高的DNA浓度和可接受的纯度,是提取基因组DNA的良好选择,并且可以用作血液来源DNA的替代品,用于筛查SDHB和SDHD突变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号